Amedisys Shares Could Have Downside to $74 a Share in a No-deal Scenario - Analyst

Seeking AlphaJun 9 20:30

Amedisys on Pace for Largest Percent Decrease Since November 2022 -- Data Talk

Amedisys, Inc. (AMED) is currently at $91.10, down $4.91 or 5.11% --Would be lowest close since April 24, 2024, when it closed at $91.05 --On pace for largest percent decrease since Nov. 2, 2022, wh

Dow JonesMay 31 22:48

Amedisys Falls Amid Report Divestiture Buyer in UnitedHealth Deal Is Gone

Seeking AlphaMay 31 22:33

Analysts' Opinions Are Mixed on These Healthcare Stocks: Nano-X Imaging (NNOX), Argenx Se (ARGX) and Amedisys (AMED)

TipRanksMay 29 20:09

Cantor Fitzgerald: Reiterates Amedisys (AMED.US) rating, adjusted from neutral to neutral, with a target price of $101.00.

Cantor Fitzgerald: Reiterates Amedisys (AMED.US) rating, adjusted from neutral to neutral, with a target price of $101.00.

Zhitong FinanceApr 25 22:20

Cantor Fitzgerald Reiterates Neutral on Amedisys, Maintains $101 Price Target

Cantor Fitzgerald analyst Sarah James reiterates Amedisys with a Neutral and maintains $101 price target.

Analyst UpgradesApr 25 22:17